Soft Tissue Infections  >>  Cubicin (daptomycin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00426933: Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

Completed
2
100
US
Daptomycin, Vancomycin
Cubist Pharmaceuticals LLC
Soft Tissue Infections
09/07
09/07

Download Options